BioArctic Collaborates with BMS for its Pyroglutamate-Amyloid-Beta Antibody Programs
Shots: BioArctic & BMS have signed a global exclusive license agreement t...
Merck Join Forces with Hansoh Pharma to Develop HS-10535
Shots: Merck and Hansoh Pharma have signed an exclusive worldwide licensing agreem...
Abilita Therapeutics and Orion Collaborate to Advance Antibodies Development in Oncology and Pain
Shots: Abilita and Orion entered into a global license and multi-target research c...
Gilead and Terray Therapeutics Partner to Discover and Develop Small Molecules for Various Targets
Shots: Gilead Sciences and Terray Therapeutics have entered into a strategic colla...
Candid Therapeutics Partners with EpimAb Biotherapeutics to Develop T-Cell Engagers for Autoimmune Indications
Shots: Candid Therapeutics has signed a strategic research collaboration agreement...
HUTCHMED Secures $10M Milestone Payment from Takeda Following the First Reimbursement of Fruzaqla in Europe
Shots: HUTCHMED to receive a $10M milestone payment by Takeda after gaining a nati...
